Avalon Pharma Signs Memorandum of Understanding with Schneider Electric to Drive Collaboration in Energy Management and Digital Transformation

Avalon Pharma has announced the signing of a Memorandum of Understanding (MoU) with Schneider Electric during the Schneider Innovation Summit 2025 held in Riyadh. The partnership aims to foster collaboration in energy management and digital transformation solutions.

Through this agreement, both parties will explore opportunities to enhance operational efficiency, optimize energy usage, and implement smart technologies that support sustainable business growth.

This strategic partnership reflects Avalon Pharma’s ongoing commitment to sustainability and innovation, leveraging artificial intelligence and advanced technologies to improve operations and customer experience — fully aligned with the objectives of Saudi Vision 2030 toward a knowledge-driven and sustainable future.